In This Section:
Jordi Rello, MD, PhD
Jordi Rello is Chief of the Critical Care Department at the Vall d’Hebron University Hospital in Barcelona, Spain, Director of the Clinical Research & Innovation in Pneumonia and Sepsis (CRISP) Group at Vall d’Hebron Research Institute, and Associate Professor of Medicine at the Universitat Autònoma de Barcelona. He earned his Doctor of Medicine with Honors and his PhD on Infectious Diseases at the University of Barcelona, Spain, followed by a residence and fellowship in Pulmonary and Critical Care at the Hospital de Sant Pau in Barcelona, Spain.
Following his specialization as intensivist in Barcelona, he received additional training on clinical epidemiology at Harvard Medical School. Early in 1994 and 1995 he was awarded the Young Investigator Award of the American College of Chest Physicians for his series of studies on risk factors for specific pathogens in ventilator-associated pneumonia (VAP). In the past he has been Director of Intensive Care and Professor of Medicine at Tarragona University Hospital.
Professor Rello is past Chair of the Infection Section of the European Society of Intensive Care Medicine and current Deputy and Head of the Working Group on Pneumonia. He was also past president of the Catalonian Society of Critical Care, and leader of the EUVAP project, the largest study on VAP management developed in Europe, contributing to a large series of papers on severe hospital-acquired pneumonia (HAP/VAP) and conducting outcomes research on pneumonia. As early as 2003, he was co-recipient of the Emmanuel Wolinski Award from the Infectious Diseases Society of America for his outstanding achievement in research on pneumonia. He reported that antibiotic therapy can be optimized in a significant portion of critically ill patients and, based on the PIRO concept, he improved the management of pneumonia.
In addition to chairing numerous committees, Professor Rello has served on the editorial boards of numerous journals, including Intensive Care Medicine, Clinical Pulmonary Medicine, Medicina Intensiva, and Enfermedades Infecciosas y Microbiologia Clinica. He has authored and co-authored more than 280 peer-reviewed articles for journals such as Annals of Internal Medicine, Lancet,
American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases, and Chest, and has co-authored several books. He is the Co-Editor of the Critical Care Infectious Diseases Textbook and Editor-in-Chief of the Perspectives on Critical Care Infectious Diseases book series.
Professor Rello speaks regularly at national and international meetings. He organized in January 2012 a ESCMID PG Course on SARI, as part of their duties as Chair of the Critically Ill Section. His areas of research include studies on prevention and control of hospital-acquired infections, sepsis and SARI. He’s an active member of ISARIC and coordinates one of the two European regional hubs. He was consultant for WHO, local and national governments in the 2009 H1N1 pandemics and have reported more than 30 originals on pandemic influenza. He was coordinator of the Spanish registry and member of the steering committee of the H1N1 ESICM Registry, reporting in September 2009 the first European series in the ICU in Crit Care, with above 150 citations. His research has focused on severe viral pneumonia, effects of oseltamivir and epidemiology and outcomes in specific groups of severe viral infection.